Expected funding for new medicines in Ireland’s ‘Budget 2025’ has been welcomed by members of the Irish pharmaceutical industry, which predicts the sector will make reimbursement applications for 36 medicines in 2025, benefitting as many as 3,700 patie…
Sanofi is emphasising the strategic importance of Belgium in its pharmaceutical research and development initiatives, while also highlighting the EU’s potential to lead an artificial intelligence-driven revolution in medicine, particularly in medicines…
The pipeline of new antibiotics to curb the antimicrobial resistance crisis remains inadequate. Belgium is developing a new antibiotic class, but success depends on securing vital support and incentives.
Irish candidates for the upcoming European parliament elections are attending a series of health manifesto events where pharmaceutical industry experts, the press and the public are quizzing candidates’ support for innovation and sustainability.
Accelerating access to innovation for patients, and providing predictability in the high-risk environment of drug making is critical, a former Dutch vaccines envoy has told Euractiv, adding that the current EU pharmaceutical framework is unsustainable …
